(Q84799627)
Statements
Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia (English)
A Caballero
R J P Magalhães
J Alonso
L López-Anglada
T Villaescusa
N Puig
J M Hernández
J Fernández-Calvo
A Aguilar
A Martín
R López
B Paiva
B Vidriales
1 February 2011